These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12462157)

  • 41. Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials.
    Karki RG; Kulkarni VM
    Bioorg Med Chem; 2001 Dec; 9(12):3153-60. PubMed ID: 11711290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design.
    Roy K; Mitra I
    Comb Chem High Throughput Screen; 2011 Jul; 14(6):450-74. PubMed ID: 21521150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inverse-QSPR for de novo Design: A Review.
    Gantzer P; Creton B; Nieto-Draghi C
    Mol Inform; 2020 Apr; 39(4):e1900087. PubMed ID: 31682079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors.
    Matter H
    J Med Chem; 1997 Apr; 40(8):1219-29. PubMed ID: 9111296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative structure-property relationships generated with optimizable even/odd Wiener polynomial descriptors.
    Ivanciuc O; Ivanciuc T; Klein DJ
    SAR QSAR Environ Res; 2001; 12(1-2):1-16. PubMed ID: 11697050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using kernel alignment to select features of molecular descriptors in a QSAR study.
    Wong WW; Burkowski FJ
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(5):1373-84. PubMed ID: 21339534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular design and QSARs/QSPRs with molecular descriptors family.
    Bolboacă SD; Jäntschi L; Diudea MV
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):195-205. PubMed ID: 23700993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fourth generation detour matrix-based topological indices for QSAR/QSPR - part-1: development and evaluation.
    Marwaha RK; Jangra H; Das KC; Bharatam PV; Madan AK
    Int J Comput Biol Drug Des; 2012; 5(3-4):335-60. PubMed ID: 23013658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparing predictive ability of QSAR/QSPR models using 2D and 3D molecular representations.
    Sato A; Miyao T; Jasial S; Funatsu K
    J Comput Aided Mol Des; 2021 Feb; 35(2):179-193. PubMed ID: 33392949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods for building quantitative structure-activity relationship (QSAR) descriptors and predictive models for computer-aided design of antimicrobial peptides.
    Taboureau O
    Methods Mol Biol; 2010; 618():77-86. PubMed ID: 20094859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small molecule databases and chemical descriptors useful in chemoinformatics: an overview.
    Gozalbes R; Pineda-Lucena A
    Comb Chem High Throughput Screen; 2011 Jul; 14(6):548-458. PubMed ID: 21521149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On the topological sub-structural molecular design (TOSS-MODE) in QSPR/QSAR and drug design research.
    Estrada E
    SAR QSAR Environ Res; 2000; 11(1):55-73. PubMed ID: 10768406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QSAR modeling using chirality descriptors derived from molecular topology.
    Golbraikh A; Tropsha A
    J Chem Inf Comput Sci; 2003; 43(1):144-54. PubMed ID: 12546547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Importance of Kier-Hall topological indices in the QSAR of anticancer drug design.
    Nandi S; Bagchi MC
    Curr Comput Aided Drug Des; 2012 Jun; 8(2):159-70. PubMed ID: 22497470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A general method for exploiting QSAR models in lead optimization.
    Lewis RA
    J Med Chem; 2005 Mar; 48(5):1638-48. PubMed ID: 15743205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions.
    Prasanth Kumar S; Jasrai YT; Pandya HA; Rawal RM
    J Biomol Struct Dyn; 2015; 33(1):56-69. PubMed ID: 24266725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Latest advances in molecular topology applications for drug discovery.
    Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
    Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bond-based global and local (bond, group and bond-type) quadratic indices and their applications to computer-aided molecular design. 1. QSPR studies of diverse sets of organic chemicals.
    Marrero-Ponce Y; Torrens F; Alvarado YJ; Rotondo R
    J Comput Aided Mol Des; 2006; 20(10-11):685-701. PubMed ID: 17186417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fragment descriptors in structure-property modeling and virtual screening.
    Varnek A
    Methods Mol Biol; 2011; 672():213-43. PubMed ID: 20838971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.